Scholars@Duke
B. Paige DePriest

B. Paige DePriest

Assistant Professor of Pediatrics
Pediatrics, Transplant and Cellular Therapy
brittany.depriest@duke.edu
2400 Pratt Street, Durham, NC 27705
2400 Pratt Street, Durham, NC 27705

Selected Publications

Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis.

Journal Article Stem Cells Transl Med · March 23, 2026 Juvenile systemic sclerosis (jSSc) is a rare, chronic, autoimmune disease in children/adolescents and is associated with significant morbidity, skin thickening/hardening (scleroderma), organ toxicity and sub-optimal therapeutic options. In this report, aut ... Full text Link to item Cite

Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma

Conference Blood · November 3, 2025 AbstractIntroduction: Brentuximab vedotin (BV) and nivolumab (N) have resulted in significant progress in the treatment of advanced-stage H ... Full text Cite

Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients: A Multi-Institutional Experience.

Journal Article Pediatr Blood Cancer · October 2025 Clostridioides difficile infection (CDI) represents a significant health risk to pediatric stem cell transplant (SCT) patients. In these patients, recurrent CDI is common, requiring prolonged antibiotic usage and increased hospitalization. Bezlotoxumab, a ... Full text Link to item Cite

Implementation of a Low-risk Algorithm for Outpatient Management of Febrile Pediatric Patients With Sickle Cell Disease

Journal Article Journal of Pediatric Hematology/Oncology · March 2025 Background:Splenic dysfunction in children with sickle cell disease (SCD) increases the risk of serious bacterial infections; therefore, families are instructed to seek medical care in th ... Full text Open Access Cite

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease

Journal Article Blood Advances · May 24, 2022 AbstractPrognostic biomarkers used to identify likelihood of disease progression have not been identified for chronic graft-versus-host disease (cGVHD), the leading cause of late nonrelapse mortality (NRM) i ... Full text Open Access Cite